Townsend Richard Nolan 4/A
4/A · Lexeo Therapeutics, Inc. · Filed Sep 10, 2025
Insider Transaction Report
Form 4/AAmended
Townsend Richard Nolan
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-08-18$4.67/sh−1,115$5,205→ 220,058 total
Footnotes (3)
- [F1]Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- [F2]On August 20, 2025, the reporting person filed a Form 4 which inadvertently reported the disposition of 2,735 securities. In fact, as reported in this amendment, the reporting person disposed of 1,115 shares of Common Stock on August 18, 2025.
- [F3]Includes 131,092 Restricted Stock Units.